Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug

Josbert J. Keller, Maria J. GT Vehreschild, Christian L. Hvas, Simon M. D. Jørgensen, Jouzas Kupciskas, Alexander Link, Chris J. J. Mulder, Simon D. Goldenberg, Ramesh Arasaradnam, Harry Sokol, Antonio Gasbarrini, Christoph Hoegenauer, Elizabeth M. Terveer, Ed J. Kuijper, Perttu Arkkila, On behalf of the UEG working group of the Standards and Guidelines initiative Stool banking for FMT

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)1408-1410
JournalUnited European Gastroenterology Journal
Volume7
Issue number10
DOIs
Publication statusPublished - 1 Dec 2019

Cite this

Keller, J. J., Vehreschild, M. J. GT., Hvas, C. L., Jørgensen, S. M. D., Kupciskas, J., Link, A., ... On behalf of the UEG working group of the Standards and Guidelines initiative Stool banking for FMT (2019). Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug. United European Gastroenterology Journal, 7(10), 1408-1410. https://doi.org/10.1177/2050640619887579